Tilray Brands, Inc. Operating Income
Tilray Brands, Inc. (TLRY) reported Operating Income of -$63.03 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-28.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-07-28
- Tilray Brands, Inc. operating income (loss) for the quarter ending 2026-05-31 was -$16.45M.
- Tilray Brands, Inc. operating income (loss) for the quarter ending 2026-02-28 was -$26.39M.
- Tilray Brands, Inc. operating income (loss) for the quarter ending 2025-11-30 was -$22.28M.
- Tilray Brands, Inc. operating income (loss) for the quarter ending 2025-08-31 was $2.09M.
- Tilray Brands, Inc. operating income (loss) for fiscal 2026 was -$63.03M.
- Tilray Brands, Inc. operating income (loss) for fiscal 2025 was -$2.28B.
- Tilray Brands, Inc. operating income (loss) for fiscal 2024 was -$174.75M.
- Tilray Brands, Inc. operating income (loss) for fiscal 2023 was -$1.37B.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-05-31 | -$16.45M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | -$42.84M derived: sum of 2 quarters · filed 2026-07-28 | -$65.12M derived: sum of 3 quarters · filed 2026-07-28 | -$63.03M 10-K · filed 2026-07-28 | ||||
| 2026-02-28 | -$26.39M 10-Q · filed 2026-04-01 | -$48.66M derived: sum of 2 quarters · filed 2026-04-01 | -$46.57M 10-Q · filed 2026-04-01 | -$1.49B derived: sum of 4 quarters · filed 2026-07-28 | ||||
| 2025-11-30 | -$22.28M 10-Q · filed 2026-01-08 | -$20.19M 10-Q · filed 2026-01-08 | -$1.46B derived: sum of 3 quarters · filed 2026-07-28 | -$2.22B derived: sum of 4 quarters · filed 2026-07-28 | ||||
| 2025-08-31 | $2.09M 10-Q · filed 2025-10-09 | -$1.44B derived: sum of 2 quarters · filed 2026-07-28 | -$2.20B derived: sum of 3 quarters · filed 2026-07-28 | -$2.24B derived: sum of 4 quarters · filed 2026-07-28 | ||||
| 2025-05-31 | -$1.44B derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | -$2.20B derived: sum of 2 quarters · filed 2026-07-28 | -$2.25B derived: sum of 3 quarters · filed 2026-07-28 | -$2.28B 10-K · filed 2026-07-28 | ||||
| 2025-02-28 | -$759.93M 10-Q · filed 2026-04-01 | -$802.15M derived: sum of 2 quarters · filed 2026-04-01 | -$838.72M 10-Q · filed 2026-04-01 | -$855.25M derived: sum of 4 quarters · filed 2026-07-28 | ||||
| 2024-11-30 | -$42.22M 10-Q · filed 2026-01-08 | -$78.79M 10-Q · filed 2026-01-08 | -$95.31M derived: sum of 3 quarters · filed 2026-07-28 | -$177.41M derived: sum of 4 quarters · filed 2026-07-28 | ||||
| 2024-08-31 | -$36.57M 10-Q · filed 2025-10-09 | -$53.10M derived: sum of 2 quarters · filed 2026-07-28 | -$135.19M derived: sum of 3 quarters · filed 2026-07-28 | -$176.95M derived: sum of 4 quarters · filed 2026-07-28 | ||||
| 2024-05-31 | -$16.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | -$98.62M derived: sum of 2 quarters · filed 2026-07-28 | -$140.38M derived: sum of 3 quarters · filed 2026-07-28 | -$174.75M 10-K · filed 2026-07-28 | ||||
| 2024-02-29 | -$82.10M 10-Q · filed 2025-04-08 | -$123.86M derived: sum of 2 quarters · filed 2025-04-08 | -$158.22M 10-Q · filed 2025-04-08 | -$248.20M derived: sum of 4 quarters · filed 2025-07-29 | ||||
| 2023-11-30 | -$41.76M 10-Q · filed 2025-01-10 | -$76.12M 10-Q · filed 2025-01-10 | -$166.10M derived: sum of 3 quarters · filed 2025-07-29 | -$1.37B derived: sum of 4 quarters · filed 2025-07-29 | ||||
| 2023-08-31 | -$34.36M 10-Q · filed 2024-10-10 | -$124.34M derived: sum of 2 quarters · filed 2025-07-29 | -$1.33B derived: sum of 3 quarters · filed 2025-07-29 | -$1.38B derived: sum of 4 quarters · filed 2025-07-29 | ||||
| 2023-05-31 | -$89.98M derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-29 | -$1.30B derived: sum of 2 quarters · filed 2025-07-29 | -$1.35B derived: sum of 3 quarters · filed 2025-07-29 | -$1.37B 10-K · filed 2025-07-29 | ||||
| 2023-02-28 | -$1.21B 10-Q · filed 2024-04-09 | -$1.26B derived: sum of 2 quarters · filed 2024-04-09 | -$1.28B 10-Q · filed 2024-04-09 | -$1.75B derived: sum of 4 quarters · filed 2024-10-10 | ||||
| 2022-11-30 | -$51.79M 10-Q · filed 2024-01-09 | -$72.97M 10-Q · filed 2024-01-09 | -$540.39M derived: sum of 3 quarters · filed 2024-10-10 | -$558.47M derived: sum of 4 quarters · filed 2024-10-10 | ||||
| 2022-08-31 | -$21.18M 10-Q · filed 2024-10-10 | -$488.60M derived: sum of 2 quarters · filed 2024-10-10 | -$506.68M derived: sum of 3 quarters · filed 2024-10-10 | -$562.21M derived: sum of 4 quarters · filed 2024-10-10 | ||||
| 2022-05-31 | -$467.42M derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30 | -$485.50M derived: sum of 2 quarters · filed 2024-07-30 | -$541.03M derived: sum of 3 quarters · filed 2024-07-30 | -$610.40M 10-K · filed 2024-07-30 | ||||
| 2022-02-28 | -$18.08M 10-Q · filed 2023-04-10 | -$19.76M 10-Q · filed 2022-04-06 | -$73.61M derived: sum of 2 quarters · filed 2023-04-10 | -$142.98M 10-Q · filed 2023-04-10 | -$216.66M derived: sum of 4 quarters · filed 2023-07-26 | |||
| 2021-11-30 | -$55.53M 10-Q · filed 2023-01-09 | -$54.68M 10-Q · filed 2022-01-10 | -$124.90M 10-Q · filed 2023-01-09 | -$123.22M 10-Q · filed 2022-01-10 | -$198.59M derived: sum of 3 quarters · filed 2023-07-26 | |||
| 2021-08-31 | -$69.37M 10-Q · filed 2022-10-07 | -$68.53M 10-Q · filed 2021-10-07 | -$143.06M derived: sum of 2 quarters · filed 2023-07-26 | |||||
| 2021-05-31 | -$73.69M derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-26 | -$132.17M 10-K · filed 2023-07-26 | ||||||
| 2021-03-31 | -$73.31M 10-Q · filed 2021-05-10 | |||||||
| 2021-02-28 | -$24.05M 10-Q · filed 2022-04-06 | -$58.48M 10-Q · filed 2022-04-06 | ||||||
| 2020-12-31 | -$21.28M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | -$201.12M 10-K · filed 2021-02-19 | ||||||
| 2020-11-30 | -$25.96M 10-Q · filed 2022-01-10 | -$34.43M 10-Q · filed 2022-01-10 | ||||||
| 2020-09-30 | -$32.77M 10-Q · filed 2020-11-09 | -$179.84M 10-Q · filed 2020-11-09 | ||||||
| 2020-08-31 | -$8.47M 10-Q · filed 2021-10-07 | |||||||
| 2020-06-30 | -$75.82M 10-Q · filed 2020-08-10 | -$147.07M 10-Q · filed 2020-08-10 | -$363.69M derived: sum of 3 quarters · filed 2021-05-10 | -$387.48M derived: sum of 4 quarters · filed 2021-05-10 | ||||
| 2020-05-31 | -$104.01M 10-K · filed 2022-07-28 | |||||||
| 2020-03-31 | -$71.25M 10-Q · filed 2021-05-10 | -$287.87M derived: sum of 2 quarters · filed 2021-05-10 | -$311.66M derived: sum of 3 quarters · filed 2021-05-10 | -$344.62M derived: sum of 4 quarters · filed 2021-05-10 | ||||
| 2019-12-31 | -$216.62M 10-K · filed 2020-03-02 | -$240.41M derived: sum of 2 quarters · filed 2020-11-09 | -$273.37M derived: sum of 3 quarters · filed 2020-11-09 | -$304.14M 10-K · filed 2021-02-19 | -$301.70M 10-K · filed 2020-03-02 | |||
| 2019-09-30 | -$23.79M 10-Q · filed 2020-11-09 | -$23.30M 10-Q · filed 2019-11-13 | -$56.75M derived: sum of 2 quarters · filed 2020-11-09 | -$85.19M 10-Q · filed 2020-11-09 | -$83.66M 10-Q · filed 2019-11-13 | -$108.10M derived: sum of 4 quarters · filed 2020-11-09 | ||
| 2019-06-30 | -$32.96M 10-Q · filed 2020-08-10 | -$32.52M 10-Q · filed 2019-08-13 | -$61.41M 10-Q · filed 2020-08-10 | -$60.39M 10-Q · filed 2019-08-13 | -$84.31M derived: sum of 3 quarters · filed 2020-08-10 | -$104.33M derived: sum of 4 quarters · filed 2020-08-10 | ||
| 2019-05-31 | -$138.93M 10-K · filed 2021-07-28 | |||||||
| 2019-03-31 | -$28.44M 10-Q · filed 2020-05-11 | -$27.87M 10-Q · filed 2019-05-15 | -$51.35M derived: sum of 2 quarters · filed 2020-05-11 | -$71.36M derived: sum of 3 quarters · filed 2020-05-11 | -$82.35M derived: sum of 4 quarters · filed 2020-05-11 | |||
| 2018-12-31 | -$22.91M 10-K · filed 2020-03-02 | -$42.92M derived: sum of 2 quarters · filed 2020-03-02 | -$53.91M derived: sum of 3 quarters · filed 2020-03-02 | -$57.84M 10-K · filed 2021-02-19 | -$57.65M 10-K · filed 2019-03-25 | |||
| 2018-09-30 | -$20.01M 10-K · filed 2020-03-02 | -$31.00M derived: sum of 2 quarters · filed 2020-03-02 | -$34.74M 10-Q · filed 2019-11-13 | -$37.35M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2018-06-30 | -$10.99M 10-K · filed 2020-03-02 | -$14.73M 10-Q · filed 2019-08-13 | -$17.34M derived: sum of 3 quarters · filed 2020-03-02 | -$19.52M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2018-03-31 | -$3.74M 10-K · filed 2020-03-02 | -$6.35M derived: sum of 2 quarters · filed 2020-03-02 | -$8.53M derived: sum of 3 quarters · filed 2020-03-02 | -$10.85M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2017-12-31 | -$2.61M 10-K · filed 2019-03-25 | -$4.79M derived: sum of 2 quarters · filed 2019-03-25 | -$7.11M derived: sum of 3 quarters · filed 2019-03-25 | -$7.50M 10-K · filed 2020-03-02 | ||||
| 2017-09-30 | -$2.18M 10-K · filed 2019-03-25 | -$4.50M derived: sum of 2 quarters · filed 2019-03-25 | -$4.90M 10-Q · filed 2018-11-14 | |||||
| 2017-06-30 | -$2.32M 10-K · filed 2019-03-25 | -$2.72M 10-Q · filed 2018-08-29 | ||||||
| 2017-03-31 | -$388.00K 10-K · filed 2019-03-25 | |||||||
| 2016-12-31 | -$7.05M 10-K · filed 2019-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |